{"id":"NCT00051168","sponsor":"Alcon Research","briefTitle":"A Long-term Safety Study of Once-daily Travatan","officialTitle":"A Long-term Safety Study of Once-daily TRAVATAN","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2009-03","completion":null,"firstPosted":"2003-01-07","resultsPosted":"2010-04-12","lastUpdate":"2011-10-07"},"enrollment":502,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma, Open-angle","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Travatan","otherNames":[]}],"arms":[{"label":"Travatan","type":"EXPERIMENTAL"}],"summary":"Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.","primaryOutcome":{"measure":"Mean Intraocular Pressure","timeFrame":"At 5 years.","effectByArm":[{"arm":"Travatan","deltaMin":16.5,"sd":2.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":99,"n":502},"commonTop":["Iris hyperpigmentation","Cataract","Hypertension","Visual acuity reduced","Ocular hyperemia"]}}